Black Box Warning Medications as Severity Evidence: What PI Attorneys Miss

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When a prescriber places a plaintiff on a medication carrying an FDA black box warning, that decision documents exceptional clinical severity. Learn how black box warning medications in pharmacy records prove that the plaintiff's condition warranted accepting serious pharmacological risks.

An FDA black box warning -- the most severe warning the agency places on a medication's labeling -- signals that the drug carries risks of serious adverse effects including organ damage, life-threatening reactions, or death. When a prescriber puts a personal injury plaintiff on a black box medication, that prescribing decision is itself evidence of exceptional injury severity. The prescriber determined that the plaintiff's condition was severe enough to justify exposing them to these elevated risks -- a clinical judgment that speaks directly to the severity of the underlying injury.

• Black box warnings are the FDA's highest safety alert, reserved for medications with risks of serious or life-threatening adverse effects
• A prescriber who chooses a black box medication over safer alternatives has made a documented clinical judgment that the plaintiff's condition warrants accepting significant pharmacological risk
• The presence of a black box medication in the regimen is evidence that the injury is not minor or easily managed -- first-line, lower-risk medications were insufficient
• LienScripts identifies every black box medication in a plaintiff's regimen and explains its significance in the MERIT (Medication Evaluation & Rationale for Injury Treatment) report
• Defense attempts to minimize injury severity are directly contradicted by the prescriber's decision to use a medication carrying the FDA's most serious safety warning

What Is a Black Box Warning?

The FDA requires a black box warning (formally called a "boxed warning") when a medication carries risks that are so significant they must be prominently displayed in a bordered box at the top of the prescribing information. This is not a routine side effect disclosure. It is the FDA's determination that prescribers and patients must be explicitly informed of serious, potentially irreversible risks before starting the medication.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "No prescriber reaches for a black box medication as a first option. These drugs are prescribed when the clinical situation demands a level of pharmacological intervention that carries real risk. In the personal injury context, that means the plaintiff's injury was severe enough that the prescriber was willing to accept black box-level risks to manage it. That is an extremely powerful statement about injury severity."

Black box warnings are not common. Only a fraction of FDA-approved medications carry this designation. When one appears in a plaintiff's pharmacy record, it deserves special attention in the demand package and at trial.

Black Box Medications Commonly Seen in PI Cases

Opioid Analgesics

All opioid medications carry a black box warning for addiction, abuse, misuse, respiratory depression, and neonatal opioid withdrawal syndrome. When a plaintiff is prescribed an opioid, the prescriber has determined that the pain is severe enough to justify these risks. Common opioids in PI cases include:

• Hydrocodone-acetaminophen (Vicodin, Norco) -- black box for addiction, respiratory depression
• Oxycodone (OxyContin, Percocet) -- black box for addiction, respiratory depression
• Morphine -- black box for addiction, respiratory depression
• Fentanyl patches -- black box for addiction, respiratory depression, accidental exposure

The prescriber's decision to initiate opioid therapy despite these black box risks directly documents that the plaintiff's pain was refractory to all safer alternatives.

Antidepressants (SSRIs/SNRIs)

SSRIs and SNRIs prescribed for post-injury depression or anxiety carry a black box warning for increased risk of suicidality in young adults. When prescribed in the PI context:

• Sertraline, escitalopram, fluoxetine -- black box for suicidality risk in patients under 25
• Duloxetine (Cymbalta) -- black box for suicidality; also used for pain management
• Venlafaxine (Effexor) -- black box for suicidality

The presence of these medications documents that the injury's psychological impact was severe enough to require pharmacological intervention despite known risks.

Skeletal Muscle Relaxants and CNS Depressants

• Carisoprodol (Soma) -- carries abuse and dependence warnings; its prescribing indicates muscle spasm refractory to safer alternatives like cyclobenzaprine
• Benzodiazepines (for acute spasm or anxiety) -- black box for combined use with opioids, abuse potential

Corticosteroids (High-Dose or Long-Term)

While individual corticosteroid formulations may not all carry black box warnings, high-dose or prolonged use carries well-documented severe risks including immunosuppression, adrenal suppression, and bone loss. Oral corticosteroid use beyond short burst courses documents inflammatory severity.

NSAIDs (Prescription Strength)

Prescription NSAIDs carry a black box warning for cardiovascular thrombotic events (heart attack, stroke) and GI bleeding. When a plaintiff requires long-term prescription NSAID therapy -- particularly celecoxib or diclofenac -- the prescriber has accepted these cardiovascular and GI risks because the inflammatory pain warrants ongoing treatment.

The Evidentiary Argument

The legal argument is straightforward: the prescriber had access to the plaintiff's complete clinical picture, weighed the risks and benefits, and determined that the plaintiff's condition was severe enough to justify a medication the FDA itself considers dangerous enough to warrant its highest warning. This is not the plaintiff's opinion. It is not the plaintiff's attorney's characterization. It is the prescriber's independent, documented clinical judgment.

Step-by-Step Presentation

1. Identify each black box medication in the pharmacy fill record
2. State the specific black box warning -- what serious risk does the FDA warn about?
3. Explain why the prescriber chose this medication over safer alternatives -- the plaintiff's condition required this level of intervention
4. Connect to the injury -- the accident caused or worsened the condition that necessitated this high-risk treatment
5. Present the prescriber's risk-benefit analysis as evidence of severity: "The plaintiff's [condition] was so severe that Dr. [Name] determined the benefits of [medication] outweighed the FDA's black box warning for [risk]"

Using Black Box Status in Demand Packages

In every demand package involving black box medications, include a dedicated section:

Medications Carrying FDA Black Box Warnings:

"The plaintiff's treatment regimen includes oxycodone 10mg, which carries the FDA's most serious warning -- a black box warning -- for addiction, abuse, respiratory depression, and death from overdose. The prescribing physician determined that the plaintiff's pain from the lumbar disc herniation was sufficiently severe to justify accepting these risks after non-opioid alternatives proved inadequate. The decision to prescribe a black box medication reflects the treating physician's clinical assessment that the injury demanded aggressive pharmacological management."

This framing forces the adjuster or mediator to confront the clinical severity reflected in the prescribing decision.

Countering Defense Arguments

"The plaintiff chose to take a dangerous medication."

The plaintiff did not prescribe the medication. A licensed physician evaluated the plaintiff's condition and made an independent clinical determination that the condition warranted a black box medication. The prescribing decision reflects the physician's assessment of severity, not the plaintiff's preference.

"Black box warnings are on many common medications."

Only a small fraction of medications carry black box warnings. The FDA reserves this designation for drugs with the most serious risk profiles. The fact that the medication is commonly prescribed does not diminish the significance of the prescriber choosing it for this plaintiff -- it means many patients have conditions severe enough to require accepting these risks, including this plaintiff.

"The plaintiff should have been treated with safer alternatives."

If safer alternatives were adequate, the prescriber would have used them. The progression from over-the-counter analgesics to prescription NSAIDs to black box medications documents that each successive level of treatment was tried and found insufficient. A MERIT report from LienScripts traces this treatment ladder, showing that the black box medication was reached through a clinically appropriate escalation process.

Multiple Black Box Medications

When a plaintiff's regimen includes two or more black box medications -- for example, an opioid and an antidepressant -- the severity argument compounds. Each black box medication represents a separate risk-benefit analysis that the prescriber determined was justified by the plaintiff's clinical condition. Multiple black box medications document a clinical picture of such severity that the prescriber accepted multiple categories of serious risk simultaneously.

The Clinical Pearl

The presence of a black box warning medication in a plaintiff's pharmacy record is not just another medication on a list. It is the prescriber's documented clinical judgment that the plaintiff's injury was severe enough to justify exposing them to the FDA's highest category of pharmacological risk. Attorneys who highlight this significance -- rather than treating all medications equally -- present a more compelling and clinically accurate severity narrative.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that identifies every black box medication and explains the clinical significance of the prescribing decision.

Related Resources

• Co-Prescribed Medications Prove Injury Severity -- How medication combinations document multi-system injury
• Dose Escalation Documents Injury Progression -- How increasing doses prove worsening symptoms